Market Indices
Sector Heatmap
IND — Xtrackers Nifty 500 India ETF
NasdaqXtrackers Nifty 500 India ETF
- O
- 21.50
- H
- 21.50
- L
- 21.50
- V
- 55.97
IND — Latest News & Headlines
20 StoriesBE Semiconductor Industries N.V. (BESI.AS) Stock Price, News, Quote & History - Yahoo! Finance Canada
BE Semiconductor Industries N.V. (BESI.AS) Stock Price, News, Quote & History Yahoo! Finance Canada
Prime Medicine stock surges on FDA IND clearance - Investing.com
Prime Medicine stock surges on FDA IND clearance Investing.com
Surrozen (SRZN) stock doubles as traders focus on IND progress and potential financing milestone - Quiver Quantitative
Surrozen (SRZN) stock doubles as traders focus on IND progress and potential financing milestone Quiver Quantitative
Dow Jones Averages | Industrial, Transportation, Utilities, & Composite - Britannica
Dow Jones Averages | Industrial, Transportation, Utilities, & Composite Britannica
About $95.1 million is expected from Surrozen’s financing after FDA cleared its eye-study application. - Stock Titan
About $95.1 million is expected from Surrozen’s financing after FDA cleared its eye-study application. Stock Titan
List of Oil & Gas Stocks in India (2026) - INDmoney
List of Oil & Gas Stocks in India (2026) INDmoney
NASDAQ Brazil Large Mid Cap Ind (^NQBRLM) Interactive Stock Chart - Yahoo! Finance Canada
NASDAQ Brazil Large Mid Cap Ind (^NQBRLM) Interactive Stock Chart Yahoo! Finance Canada
Solar Industries India (NSEI:SOLARINDS) Stock Forecast & Analyst Predictions - Simply Wall Street
Solar Industries India (NSEI:SOLARINDS) Stock Forecast & Analyst Predictions Simply Wall Street
Prime Medicine stock holds at outperform on FDA IND clearance - Investing.com
Prime Medicine stock holds at outperform on FDA IND clearance Investing.com
Gandhar Oil Refine Ind L Share Price Target, Forecast for Long Term Equity. - HDFC Sky
Gandhar Oil Refine Ind L Share Price Target, Forecast for Long Term Equity. HDFC Sky
FDA clears Immunome to test a cancer drug in people; a study is expected in the fourth quarter of 2026. - Stock Titan
FDA clears Immunome to test a cancer drug in people; a study is expected in the fourth quarter of 2026. Stock Titan
Page Ind stock reports Q1 FY27 revenue growth with volume lagging - AD HOC NEWS
Page Ind stock reports Q1 FY27 revenue growth with volume lagging AD HOC NEWS
ACHP.TO Interactive Stock Chart | GLOBAL X ASIA SEMICONDUCTOR IND Stock - Yahoo Finance
ACHP.TO Interactive Stock Chart | GLOBAL X ASIA SEMICONDUCTOR IND Stock Yahoo Finance
PI Industries (NSEI:PIIND) Stock Forecast & Analyst Predictions - Simply Wall Street
PI Industries (NSEI:PIIND) Stock Forecast & Analyst Predictions Simply Wall Street
Orient Cables (India) Ltd Share Price Today – Live NSE/BSE - INDmoney
Orient Cables (India) Ltd Share Price Today – Live NSE/BSE INDmoney
The FDA cleared Palisade Bio’s Crohn’s trial application. First patient dosing is targeted for early 2027. - Stock Titan
The FDA cleared Palisade Bio’s Crohn’s trial application. First patient dosing is targeted for early 2027. Stock Titan
KEI Industries Limited (KEI.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada
KEI Industries Limited (KEI.NS) Stock Price, News, Quote & History Yahoo! Finance Canada
^NQBRLM Interactive Stock Chart | NASDAQ Brazil Large Mid Cap Ind Stock - Yahoo Finance - Yahoo! Finance Canada
^NQBRLM Interactive Stock Chart | NASDAQ Brazil Large Mid Cap Ind Stock - Yahoo Finance Yahoo! Finance Canada
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History Yahoo! Finance Canada
Rs 4 lakh crore loss! Why India's storied consumer stocks are languishing near the bottom in 2026 - The Economic Times
Rs 4 lakh crore loss! Why India's storied consumer stocks are languishing near the bottom in 2026 The Economic Times